retatrutide triple agonist obesity Phase 3 TRIUMPH-4 Results: 28.7% Weight Loss & What It Means for the Peptide Industry retatrutide phase 2 trial obesity

A single shot can give a short-term lift, while a regular schedule supports steadier results

Wei W, Lyu X, Markhard AL, Fu S, Mardjuki RE, Cavanagh PE, et al

Their entire bodies may feel sore, drained, and overall in need of relief

Tucker, M

It affects males and females equally and usually develops during the first three decades of life

Oshman concurs with that sentiment and also wants patients to understand that starting on a GLP-1 medication for weight loss and/or Type 2 diabetes control is a long-term commitment and that you are likely going to have to take some form of a GLP-1 drug for the rest of your life, or at least for many years, depending on how these medications develop in the future. That's because research shows that, for 90% of patients, when they go off a GLP-1 medication, they rapidly regain the weight they lost and experience a reversal of the health benefits they attained while on the drug